(A)nalysis of immunological (VA)riables in ex vivo (T)ofacitinib-treated human biopsies from (A)ctive ulcerative colitis patients to predict clinical (R)esponse (the AVATAR study)
Latest Information Update: 11 Dec 2020
At a glance
- Drugs Tofacitinib (Primary)
- Indications Ulcerative colitis
- Focus Pharmacodynamics
- Acronyms AVATAR
- 11 Dec 2020 New trial record